CCN1 EXPRESSION BY FIBROBLASTS HAS A ROLE IN BLEOMYCIN INDUCED SKIN FIBROSIS AND IS A POTENTIAL TARGET FOR ANTI-FIBROTIC THERAPY IN SCLERODERMA

被引：0
|
作者：
Quensel, K. [1 ]
Hutchenreuther, J. [1 ]
Xu, S. [2 ]
Hinz, B. [3 ]
Siqueira, W. [1 ]
O'Gorman, D. [4 ]
Stratton, R. [2 ]
Leask, A. [1 ]
机构：
[1] Univ Western Ontario, Dent, London, England
[2] UCL, London, England
[3] Univ Toronto, Toronto, ON, Canada
[4] Lawson Res Inst, London, ON, Canada
来源：
WOUND REPAIR AND REGENERATION | 2020年 / 28卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
A-109
引用
收藏
页码：A12 / A12
页数：1
相关论文
共 39 条
  • [1] CCN1 EXPRESSION BY FIBROBLASTS IS REQUIRED FOR BLEOMYCIN-INDUCED SKIN SCLERODERMA
    Thompson, Katherine
    Leask, Andrew
    RHEUMATOLOGY, 2015, 54 : 142 - 143
  • [2] Thrombin-induced CCN2 expression as a target for anti-fibrotic therapy in scleroderma
    Andrew Leask
    Journal of Cell Communication and Signaling, 2010, 4 : 111 - 112
  • [3] Thrombin-induced CCN2 expression as a target for anti-fibrotic therapy in scleroderma
    Leask, Andrew
    JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2010, 4 (02) : 111 - 112
  • [4] Basophil Plays Anti-Fibrotic Role In Bleomycin Induced Lung Fibrosis
    Tateishi, T.
    Miyazaki, Y.
    Karasuyama, H.
    Inase, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [5] Cyclosporin A has anti-fibrotic effects in human lung fibroblasts and in bleomycin-induced lung fibrosis model mice
    Yamazaki, Risa
    Fujita, Tetsuo
    Yanagihara, Madoka
    Nakamura, Hiroyuki
    Fujino, Hiromichi
    Kasuya, Yoshitoshi
    Murayama, Toshihiko
    FASEB JOURNAL, 2016, 30
  • [6] Cyclosporin A has anti-fibrotic effects in human lung fibroblasts and in bleomycin- induced lung fibrosis model mice
    Yamazaki, Risa
    Fujita, Tetsuo
    Yanagihara, Madoka
    Nakamura, Hiroyuki
    Fujino, Hiromichi
    Kasuya, Yoshitoshi
    Murayama, Toshihiko
    FASEB JOURNAL, 2016, 30
  • [7] SMAC Mimetic as potential anti-fibrotic therapy in an in vivo model of Bleomycin-induced Pulmonary Fibrosis
    Vanegas, Natalia-Del Pilar
    Rosas, Lorena
    Garcia, Paula Agudelo
    Scott, Stephanie
    Riley, Madeline
    Dale, Erica L.
    Calyeca, Jazmin
    Peters, Victor
    Kaestle, Marc
    Seither, Peter
    Mora, Ana L.
    Rojas, Mauricio
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [8] Analysis of the Anti-fibrotic Potential of JAK Inhibitors in a Bleomycin-induced Pulmonary Fibrosis Model
    Murakami, K.
    Nishimura, H.
    Kawano, H.
    Danzan, N.
    Yamashita, Y.
    Haji, K.
    Naito, N.
    Koyama, K.
    Sato, S.
    Nishioka, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [9] Evaluation of potential anti-fibrotic effect of oleuropein on bleomycin-induced pulmonary fibrosis in rat
    Khalili, Hamid Reza
    Adeli Behrooz, Hamid Reza
    Rashidi Nooshabadi, Mohammad Reaza
    Geravandi, Sahar
    Mohammadi, Mohammad Javad
    Foruozandeh, Hossein
    TOXIN REVIEWS, 2020, 39 (02) : 188 - 196
  • [10] Tubulointerstitial De Novo Expression of the α8 Integrin Chain in a Rodent Model of Renal Fibrosis - A Potential Target for Anti-Fibrotic Therapy?
    Hartner, Andrea
    Menendez-Castro, Carlos
    Cordasic, Nada
    Marek, Ines
    Volkert, Gudrun
    Klanke, Bernd
    Rascher, Wolfgang
    Hilgers, Karl F.
    PLOS ONE, 2012, 7 (11):
1234